Artisan Partners Limited Partnership Takes $24.57 Million Position in HealthEquity, Inc. (NASDAQ:HQY)

Artisan Partners Limited Partnership bought a new stake in shares of HealthEquity, Inc. (NASDAQ:HQY) during the 4th quarter, according to its most recent filing with the SEC. The fund bought 256,051 shares of the company’s stock, valued at approximately $24,568,000. Artisan Partners Limited Partnership owned approximately 0.30% of HealthEquity as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Arcadia Investment Management Corp MI acquired a new position in HealthEquity during the fourth quarter worth $26,000. Smartleaf Asset Management LLC increased its position in shares of HealthEquity by 34.3% during the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock worth $37,000 after purchasing an additional 98 shares in the last quarter. Proficio Capital Partners LLC bought a new position in HealthEquity during the 4th quarter valued at about $39,000. UMB Bank n.a. boosted its position in HealthEquity by 65.6% in the fourth quarter. UMB Bank n.a. now owns 414 shares of the company’s stock valued at $40,000 after buying an additional 164 shares in the last quarter. Finally, Skandinaviska Enskilda Banken AB publ grew its stake in HealthEquity by 1,934.8% during the fourth quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company’s stock worth $45,000 after buying an additional 445 shares during the last quarter. Institutional investors own 99.55% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on the stock. KeyCorp cut their target price on shares of HealthEquity from $120.00 to $110.00 and set an “overweight” rating for the company in a research note on Monday, March 24th. Raymond James raised HealthEquity from an “outperform” rating to a “strong-buy” rating and reduced their price objective for the stock from $120.00 to $115.00 in a research note on Tuesday. Barrington Research restated an “outperform” rating and issued a $112.00 target price on shares of HealthEquity in a research note on Friday, March 14th. Royal Bank of Canada upped their price target on shares of HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 10th. Finally, The Goldman Sachs Group lowered their price objective on shares of HealthEquity from $107.00 to $94.00 and set a “neutral” rating for the company in a research report on Thursday. One research analyst has rated the stock with a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Buy” and a consensus price target of $112.23.

Insider Transactions at HealthEquity

In other news, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction on Monday, February 10th. The shares were sold at an average price of $111.29, for a total transaction of $639,917.50. Following the transaction, the director now directly owns 78,219 shares of the company’s stock, valued at $8,704,992.51. This trade represents a 6.85 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 2.20% of the company’s stock.

HealthEquity Stock Down 2.1 %

Shares of HealthEquity stock opened at $86.96 on Friday. The business has a fifty day simple moving average of $103.63 and a 200 day simple moving average of $95.91. The stock has a market cap of $7.52 billion, a PE ratio of 79.78, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a 12 month low of $65.01 and a 12 month high of $115.59.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.